miguel regueiro, m.d. professor of medicine associate chief, education
DESCRIPTION
What adverse reactions to immunomodulators and biologics: 1) mandate discontinuation of therapy and 2) when can medications be continued?. Miguel Regueiro, M.D. Professor of Medicine Associate Chief, Education Clinical Head and Co-Director, IBD Ctr University of Pittsburgh Medical Ctr. - PowerPoint PPT PresentationTRANSCRIPT
1
What adverse reactions to immunomodulators and biologics:
1) mandate discontinuation of therapy and
2) when can medications be continued?
Miguel Regueiro, M.D.
Professor of Medicine
Associate Chief, Education
Clinical Head and Co-Director, IBD Ctr
University of Pittsburgh Medical Ctr
Very little to no evidenced based data on this subject, so…
I called some friends for help.
2
Corey Siegel – after 1 minute of laughter, “I was asked to give this talk and turned
it down…good luck!”
3
David Rubin – “What are you kidding me?!?!”
4
Asher Kornbluth – “I’m sorry, I can’t
hear you.”
Ed Loftus – Clearly has gone over his own cliff…….
Jean Fred Colombel – yelled something in French about the color blue being
sacred, the rest I couldn’t understand.
7
So, with no help from my “friends”
8
I will give you my opinion on what to do with IMMs/antiTNFs when an AE occurs.
We need to individualize this decision based on severity of IBD and AE.
I look forward to further discussion and opinion in the panel session.
9
What are the main side-effects of 6MP/Azathioprine?
Siegel CA, et al. APT 2005 (weighted average); Siegel CA, et al. CGH 2009; Beaugerie L, et al. Lancet 2009.
EventFrequency Estimate
Stop therapy due to AE 11%
Allergic reactions 2%
Nausea 2%
Hepatitis 2%
Pancreatitis 3%
Serious infections 5%
non-Hodgkin’s lymphoma 0.04%-0.09% (4-9/10,000)
Adverse Events Associated with anti-TNF Treatment
Siegel CA.. The inflammatory bowel disease yearbook, volume 6. 2009; Infliximab package insert; Vermeire, Gastro 2003; Cush, Ann Rheum Dis 2005; Lenercept study group, Neurology 1999; ATTACH trial 2003
Event Estimated Frequency
Stop therapy due to adverse event 10%
Infusion or injection site reactions 3%-20%
Drug related lupus-like reaction 1%
Serious infections 3%
Skin ? 1-20%
Tuberculosis 0.05% (5/10,000)
Non-Hodgkin’s lymphoma (combo) 0.06% (6/10,000)
Multiple sclerosis, heart failure, serious liver injury
Case reports only
Continue or Stop Rxent?Focus on three adverse event
categories – cases from my clinic
• Infections
• Malignancy
• Skin Complications
• Thank you Drs Siegel, Rubin, Loftus, Kornbluth, and Colombel for your slides
12
Infections - Continue or Stop?
• 33 yo CD IFX/AZA recently relocated from Louisville to Pittsburgh.
• For the past month he had cough, myalgias, weight loss, and low grade fevers.
• PPD/Quantiferon negative, but CXR shows……..
13
CXR – Reticulonodular infiltrate
14
Bronchoscopy – what is the dx?
15
Histoplasmosis
• Urine antigen also positive for Histoplasmosis
• Stop AZA/IFX and rx ketoconazole
• Would you restart IFX/AZA after infxn clears?
16
Increased Risk of Opportunistic Infections (Mayo) – AZA/antiTNF
Medication Odds Ratio (95% CI) P value
Any Medication(5-ASA, AZA/6-MP,
steroids, MTX, infliximab)
3.5 (2 - 6.1) <0.0001*
5-ASA 1.0 (0.6 - 1.6) 0.94
Corticosteroids 3.4 (1.8 - 6.2) <0.0001*
6-MP/azathioprine 3.1 (1.7 - 5.5) 0.0001*
Methotrexate 4.0 (0.4 - 44.1) 0.26
Infliximab 4.4 (1.2 - 17.1) 0.03
Toruner M et al, Gastroenterology 2008; 134:929-36.
Older Age Is Associated with Opportunistic Infections
• Age at IBD diagnosis:–Odds Ratio (per 5 years), 1.1 (1.1-1.2)
• Age at first Mayo visit:– 0 – 23 1.0 (reference)–24 – 36 1.2 (0.5 – 2.8)–37 – 49 1.1 (0.5 – 2.5)– ≥ 50 3.0 (1.2 – 7.2)
Toruner M et al, Gastroenterology 2008; 134:929-36..
The type of infections more prevelant with anti-TNFs (granulomatous)
• Bacterial•Tuberculosis•Atypical mycobacterial infection•Listeriosis
• Invasive Fungal•Histoplasmosis•Coccidioidomycosis•Candidiasis•Aspergillosis•Pneumocystosis
20
Lee JH et al. Arthritis Rheum. 2002;46:2565-70Velayos FS et al. Inflamm Bowel Dis. 2004;10:657-60Bergstrom L et al. Arthritis Rheum. 2004;50:1959-66
Case - Stop or Continue?
• 27 yo male with a h/o severe Crohn’s ds who is in remission for 4 years on 6MP 1 mg/kg.
• Over the past year he has had recurrent “bumps” over his hands and arms.
• Not painful, but aesthetically displeasing and affecting social life
23
What is the diagnosis?
24
Warts (likely papillomavirus)
• Despite treatment he continues to have problems with warts.
• The 6MP is lowered but it is not until 6MP is stopped that his warts resolve.
• Can 6MP be started again in the future?
25
Prospective study (n=230)Prospective study (n=230)
Seksik P et al. Aliment Pharmacol Ther 2009;29:1106-Seksik P et al. Aliment Pharmacol Ther 2009;29:1106-13.13.
Thiopurines Increase the Incidence of Certain Viral Infections - Warts
Infe
ctio
n/p
atie
nt-
year
Infe
ctio
n/p
atie
nt-
year
2.02.0
1.51.5
1.01.0
0.50.5
00AZA+AZA+n=169n=169
AZA–AZA–n=61n=61
AZA+AZA+n=169n=169
AZA–AZA–n=61n=61
NSNS
**
Upper respiratory Upper respiratory tract infectionstract infections
Herpes virus flare-upsHerpes virus flare-ups
AZA+AZA+ AZA–AZA– AZA+AZA+ AZA–AZA–
Warts at the entryin the study
Appearance of increased Appearance of increased number of wartsnumber of warts
NSNS
**
Pat
ien
ts (
%)
Pat
ien
ts (
%)
2020
1818
1616
1414
1212
1010
88
66
44
22
00
NS = not significantNS = not significant
Case - Continue or Stop?
• 58 yo in remission on IFX monotx for 5yrs (first 1.5 yrs on 6MP as well).
• Due for IFX infusion in 3 weeks.
• 1 wk ago developed severe pain along back, “thought kidney stone”
• 4 days ago developed “blisters” along back (very painful)
27
Diagnosis? Give IFX in 3 weeks?
28
Does Zoster mandate stopping?
• If pt due for antiTNF and active zoster, I wait for blisters to “dry/scab”
• In this case she received IFX on schedule as her lesions resolved
• Side Note: Shingles vaccine is live and contraindicated in immunosuppressed patients
29
Case - Continue or Stop?
• 41 yo UC in remission on Adalimumab 40mg qow and 6MP 50mg/d for 3 yrs
• 2 weeks ago worsening diarrhea – no bleeding, but “feels like flare”
• Colonoscopy shows……..
30
What is your dx and would you change the ADA/6MP?
31
Clostridium difficile Infection and IBDIncreasing percentage of C. diff Increasing percentage of C. diff
infections are IBD patientsinfections are IBD patients
Increasing number of Increasing number of hospitalizations in IBD hospitalizations in IBD
patients with patients with C. diffC. diff
Issa M, et al. Clin Gastroenterol Hepatol 2007; 5: 345-51.
•Classic risk factors disappearing•Pseudomembranes usually not present•Low threshold for checking in IBD patients with flares
•Should you stop immunosuppression? Conflicting data
Infections: Stop or Continue?What I do….Consult with ID..then..
34
VIRALEBV, HSV, CMV, HIV, HepB, HepC,HPV
BACTERIALStrep/StaphMycobact
FUNGALHistoplasmCoccidio
OtherC Diff
Thiopurine
antiTNF
Infections: Stop or Continue?What I do….
35
VIRALEBV, HSV, CMV, HIV, HepB, HepC,HPV
BACTERIALStrep/StaphMycobact
FUNGALHistoplasmCoccidio
OtherC Diff
Thiopurine Stop if severe:
Individualize as to who to restart 6MP/AZA
antiTNF
Infections: Stop or Continue?What I do….
36
VIRALEBV, HSV, CMV, HIV, HepB, HepC,HPV
BACTERIALStrep/StaphMycobact
FUNGALHistoplasmCoccidio
OtherC Diff
Thiopurine StopMay need to stop + Rx virus
Individualize as to who to restart 6MP/AZA
antiTNF Continue Prob ok to continue, except active Hep B
Infections: Stop or Continue?
37
VIRALEBV, HSV, CMV, HIV, HepB, HepC,HPV
BACTERIALStrep/StaphMycobact
FUNGALHistoplasmCoccidio
OtherC Diff
Thiopurine StopMay need to stop + Rx virus
Individualize as to who to restart 6MP/AZA
Stop + Rxthen individualize(if typical bact, eg strep, often can rx through)
antiTNF Continue Prob ok to continue, except active Hep B
Stop + Rxthen individualize(if typical bact, eg strep, often can rx through)
Infections: Stop or Continue?What I do….
38
VIRALEBV, HSV, CMV, HIV, HepB, HepC,HPV
BACTERIALStrep/StaphMycobact
FUNGALHistoplasmCoccidio
OtherC Diff
Thiopurine StopMay need to stop + Rx virus
Individualize as to who to restart 6MP/AZA
Stop + Rxthen individualize
Stop + Rx then Restart when cleared
antiTNF Continue Prob ok to continue, except active Hep B
Stop + Rxthen individualize
Stop + Rx then Restart when cleared
Infections: Stop or Continue?What I do….
39
VIRALEBV, HSV, CMV, HIV, HepB, HepC,HPV
BACTERIALStrep/StaphMycobact
FUNGALHistoplasmCoccidio
OtherC Diff
Thiopurine StopMay need to stop + Rx virus
Individualize as to who to restart 6MP/AZA
Stop + Rxthen individualize
Stop + Rx then Restart when cleared
Probably continue
antiTNF Continue Prob ok to continue, except active Hep B
Stop + Rxthen individualize
Stop + Rx then Restart when cleared
Probably continue
Malignancy
-Lymphoma
- Solid Tumors
40
Case – Stop or Continue?
• 39 yo male CD in remission on 6MP/IFX for 8 yrs.
• Now with weight loss, sweats, and low grade fevers
41
Large periaortic LNs involving left renal cortex – diagnosis?
42
Non-Hodgkin’s Lymphoma
• What do you do now?
• Stop IFX and continue 6MP?
• Stop 6MP and continue IFX?
• Stop both?
43
In contrast: Hepatosplenic T cell lymphoma – enlarged spleen, otherwise
nonspecific
44
AZA/6-MP are probably related to Lymphoma (Meta-analysis): SIR 4.06
AuthorAuthor ObservedObserved ExpectedExpected
ConnellConnell 00 0.520.52
KinlenKinlen 22 0.240.24
FarrellFarrell 22 0.050.05
LewisLewis 11 0.640.64
FraserFraser 33 0.650.65
KorelitzKorelitz 33 0.610.61
TotalTotal 1111 2.712.71
SIR = 4.06, 95% CI 2.01 – 7.28Kandiel A et al. Gut. 2005:54:1121-25
CESAME – 6MP/AZA OnlyLymphoma: HR 5.3
At cohort entry
N # Lymphomas
HR (95% CI)
Never exposed to thiopurines
10,810 6 Reference
On therapy with thiopurines
5,867 16 5.3 (2.0 – 13.9)
Previously discontinued thiopurines
2,809 2 1.0 (0.2 – 5.1)
Beaugerie L. Lancet 2009 DOI:10.1016/S0140-6736(09)61302-7
• 8905 patients representing 20,602 pt-years of exposure
• 13 Non-Hodgkin’s lymphomas
• Mean age 52, 62% male
• 10/13 exposed to IM* (really a study of combo Rx)
Risk of NH Lymphoma with anti-TNF + IM treatment for Crohn’s Disease: A Meta-Analysis
NHL rate per 10,000
SIR 95% CI
SEER all ages 1.9 - -
IM alone 3.6 - -
Anti-TNF + IM vs SEER 6.1 3.23 1.5-6.9
Anti-TNF+ IM vs IM alone 6.1 1.7 0.5-7.1
Siegel et al, CGH 2009;7:874. *not reported in 2
6.1 per 10,000 pt-years
CESAME – Combo 6MP/AZA and antiTNF: SIR = 10.2
Therapy Patients # Lymph SIR 95% CI
Never thiopurine or TNF
22,706 6 1.5 0.5 – 3.2
Current thiopurine without TNF
14,729 13 6.5 3.5 – 11.2
Current thiopurine + TNF
1,929 2 10.2 1.2 – 36.9
Beaugerie L. Lancet 2009 DOI:10.1016/S0140-6736(09)61302-7
Case Continue or Stop?
• 58 yo female with severe UC who has been on IFX/6MP (50mg/d) for past 1yr
• Just diagnosed with intraductal breast CA (T1N0MX)
• Strong FHx breast CA, pt opts for bilateral mastectomy
• After consultation with oncology, the decision is to cont meds
49
No clear association between thiopurines/antiTNFs and solid tumors
in IBD
Study Types of cancer
Number of patients
Statistically significant
Armstrong 2010 lung, breast 1955 NO
Fraser 2002breast,
bronchial, renal6262 NO
Connell 1994gastric, lung,
breast, cervical755 NO
…..but DO seem associated with increased risk of skin cancers and lymphoma
Malignancy: Stop or Continue? What I doConsult with Oncology and then.….
51
LYMPHOMA HSTC Lymphoma SOLID TUMORS
Thiopurine
antiTNF
Malignancy: Stop or Continue? What I doConsult with Oncology and then.….
52
LYMPHOMA HSTC Lymphoma SOLID TUMORS
Thiopurine Continue or start:Previously Rx’d and inactive >1 yr
antiTNF Continue or start:Previously Rx’d and inactive >1 yr
Malignancy: Stop or Continue? What I doConsult with Oncology and then.….
53
LYMPHOMA HSTC Lymphoma SOLID TUMORS
Thiopurine Continue or start:Previously Rx’d and inactive >1 yr
Stop:New Lymphoma, esp EBV on 6MP
antiTNF Continue or start:Previously Rx’d and inactive >1 yr
Stop:New Lymphoma?Restart
Malignancy: Stop or Continue? What I doConsult with Oncology and then.….
54
LYMPHOMA HSTC Lymphoma SOLID TUMORS
Thiopurine Continue or start:Previously Rx’d and inactive >1 yr
Stop:New Lymphoma, esp EBV on 6MP
Must Stop:
-Has been a fatal lymphoma.
-Even if eradicated, avoid future 6MP
antiTNF Continue or start:Previously Rx’d and inactive >1 yr
Stop:New Lymphoma, esp EBV on 6MP
Malignancy: Stop or Continue? What I doConsult with Oncology and then.….
55
LYMPHOMA HSTC Lymphoma SOLID TUMORS
Thiopurine Continue or start:Previously Rx’d and inactive >1 yr
Stop:New Lymphoma, esp EBV on 6MP
Must Stop:
-Has been a fatal lymphoma.
-Even if eradicated, avoid future 6MP
antiTNF Continue or start:Previously Rx’d and inactive >1 yr
Stop:New Lymphoma, esp EBV on 6MP
Must Stop:-Has been a fatal lymphoma.
-Even if eradicated, avoid future antiTNF?
Malignancy: Stop or Continue? What I doConsult with Oncology and then.….
56
LYMPHOMA HSTC Lymphoma SOLID TUMORS
Thiopurine Continue or start:Previously Rx’d and inactive >1 yr
Stop:New Lymphoma, esp EBV on 6MP
Must Stop:
-Has been a fatal lymphoma.
-Even if eradicated, avoid future 6MP
Continue or start:
-Previously Rx’d
-even active (non-EBV) solid tumors ok to continue
antiTNF Continue or start:Previously Rx’d and inactive >1 yr
Stop:New Lymphoma, esp EBV on 6MP
Must Stop:-Has been a fatal lymphoma.
-Even if eradicated, avoid future antiTNF?
Malignancy: Stop or Continue? What I doConsult with Oncology and then.….
57
LYMPHOMA HSTC Lymphoma SOLID TUMORS
Thiopurine Continue or start:Previously Rx’d and inactive >1 yr
Stop:New Lymphoma, esp EBV on 6MP
Must Stop:
-Has been a fatal lymphoma.
-Even if eradicated, avoid future 6MP
Continue or start:
-Previously Rx’d
-even active (non-EBV) solid tumors ok to continue
antiTNF Continue or start:Previously Rx’d and inactive >1 yr
Stop:New Lymphoma, esp EBV on 6MP
Must Stop:-Has been a fatal lymphoma.
-Even if eradicated, avoid future antiTNF?
Start: Previously Rx’d
Malignancy: Stop or Continue? What I doConsult with Oncology and then.….
58
LYMPHOMA HSTC Lymphoma SOLID TUMORS
Thiopurine Continue or start:Previously Rx’d and inactive >1 yr
Stop:New Lymphoma, esp EBV on 6MP
Must Stop:
-Has been a fatal lymphoma.
-Even if eradicated, avoid future 6MP
Continue or start:
-Previously Rx’d
-even active (non-EBV) solid tumors ok to continue
antiTNF Continue or start:Previously Rx’d and inactive >1 yr
Stop:New Lymphoma, esp EBV on 6MP
Must Stop:-Has been a fatal lymphoma.
-Even if eradicated, avoid future antiTNF?
Start: Previously Rx’d
Stop:Active cancer (but unless mets, ok to restart once rx’d?)
I think skin AEs are increasing and becoming
most problematic
Skin AEs secondary to Meds
- Malignancy
- Immune mediated
-Thank you, Jean Fred for your slides
60
Do GI’s know Skin?
61
62
Plantar Psoriasis
Nodular Pigmented BCC
Basal Cell Cancer
Squamous Cell Ca
Take home message:
Get Dermatology involved!
63
What’s the dx? Stop or Cont ADA?
• 67 yo m CD remission 3 yrs ADA – has 15 of these lesions removed over past 2 years
64
Stop or Continue – Basal Cell CA
• 67 yo m CD remission 3 yrs ADA – 15 basal cells removed over past 2 years
• He opts to continue ADA given good CD response.
• He follows closely with derm – for smaller lesions topical 5FU has been effective.
65
What is this? What do you do?
• 59 yo f CD sun exposure entire life – deep remission on 6MP for 15 years
• Last 2 yrs has had Moh’s surgery x 2 to remove these lesions from face – 3 from neck
66
Stop or Continue – Squamous Cell cancer
• The 6MP is stopped and in the next 2 years she has had 1 more SCC but her CD remains in remission
67
Yea
rly
inci
den
ce r
ate
(per
1,0
00
pat
ien
t-ye
ars)
32 incident NMSC: 20 BCC and 12 SCC
Continuing
Discontinued
Never received
<50 years
50-65 years
>65 yearsThiopurine therapy
Cases of NMSC (n)
Patient-years
039 336 233
15736792413590 496815302319 2383526743
6
3
4
5
1
2
0
High Rates of BCC and SCC in IBD pts exposed to thiopurines – active or previous exposure
Peyrin-Biroulet. Gastroenterology 2011
• Prospective observational registries and studies
• Patients with RA, PsA or ankylosing Spondylitis receiving TNFi therapy
Patients treated with TNFi have a significantly
increased risk ofdeveloping an NMSC
(1.45, 95% CI 1.15 to 1.76).
Mariette X. Ann Rheum Dis. 2011
Anti-TNFs also associated with Basal Cell and Squamous Cell Cancers
• Retrospective cohort (and nested case-control) study
• LifeLink claims database 108,518 IBD pts• Crohn’s (but not UC) associated with
increased risk of melanoma (IRR 1.45, 95% CI 1.13-1.85)
• Biologics increased risk of melanoma
Melanoma and anti-TNF therapy in IBD
Long M, et al. Gastroenterology 2012. Epub ahead of print.
OR 1.88 (95% CI 1.08-3.29)
What is your dx? How do you rx?• 27 yo female CD on ADA in remission
for 3 yrs but over past 6 mos develops progressive skin lesions over ears and scalp (with hair loss)
74
Anti-TNF psoriaform lesions – in my opinion the most common and
difficult antiTNF AE to manage
• She sees dermatology who tries topical treatment (steroids, dapsone) without benefit.
• They recommend adding MTX but she wants to have children soon
• She stops the ADA. Her skin improves and 1 yr later she is pregnant but is beginning to have CD sx’s.
75
What about this case? Fungal? Other?
• 25 yo male UC on IFX in remission but over past 6 mos has patchy skin lesions under the arms and gluteal cleft
76
“Inverse Psoriasis” from antiTNF• His skin improves with topical steroids/dapsone but
not completely
• After adding MTX 10mg per week the lesions resolve.
77
Psoriasis associated with Anti-TNF therapy
• Described with all the anti-TNF: class effect
• Described in patients receiving treatment for diverse indications (RA, IBD, psoriasis, psoriatic arthritis, ankylosing spondylitis)
• Often leads to therapy discontinuation
• First IBD case reported in 2004 in a CD patient treated with infliximab
Verea MM. Ann Pharmacther 2004; (1) G. Fiorino. APT 2009; (2) Cullen G. In press 2011
November 2008 (1) August 2011 (2)
Increasingly recognised side-effect of anti-TNF
therapy in the IBD literature
Psoriasis associated with Anti-TNF therapy
FDA WARNING
Psoriasis associated with Anti-TNF therapyWhat is the magnitude of the problem in IBD patients?
Cullen G. APT 2011
Psoriasis associated with Anti-TNF therapy in IBD: a new series and review of 120 cases from the Literature
Case reports (50) + current series(30) + GETAID Series (62)150 cases for analysis
Psoriasis details
Location: •Palmoplantar - 42%•Scalp - 42%•Trunk – 31%•Flexures – 31%•Facial – 16%
When you see this –think antiTNF mediated Psoriasis
• Several phenotypes:• Palmoplantar pustular psoriasis: form most commonly associated
with anti-TNF therapy (even in patients treated for plaque psoriasis)
JF Rahier.CGH 2010; Courtesy of Franck Delesalle
….or this……antiTNF Psoriasis
•Several phenotypes:• Inverse psoriasis (type of psoriasis in plaques)
In Psoriasis – Manson publishing; Courtesy of Franck Delesalle
Skin: Stop or Continue? What I do-Consult with Dermatology and then.….
87
NMSC – Basal Cell Squamous Cell
Melanoma PSORIASIAS-like(Immune mediated)
Thiopurine
antiTNF
Skin: Stop or Continue? What I do-Consult with Dermatology and then.….
88
NMSC – Basal Cell Squamous Cell
Melanoma PSORIASIAS-like(Immune mediated)
Thiopurine Continue or start:Active or Past, as long as Dermatology monitoring
Stop:Only if significant recurrence or potential for disfiguring sequelae
antiTNF
Skin: Stop or Continue? What I do-Consult with Dermatology and then.….
89
NMSC – Basal Cell Squamous Cell
Melanoma PSORIASIAS-like(Immune mediated)
Thiopurine Continue or start:Active or Past, as long as Dermatology monitoring
Stop:Only if significant recurrence or potential for disfiguring sequelae
antiTNF Continue or start:Active or Past, as long as Dermatology monitoring
Stop:Rarely necessary
Skin: Stop or Continue? What I do-Consult with Dermatology and then.….
90
NMSC – Basal Cell Squamous Cell
Melanoma PSORIASIAS-like(Immune mediated)
Thiopurine Continue or start:Active or Past, as long as Dermatology monitoring
Stop:Only if significant recurrence or potential for disfiguring sequelae
Continue/start:-eradicated-melanoma free for > 1 yr-no mets
Stop: New Onset?
antiTNF Continue or start:Active or Past, as long as Dermatology monitoring
Stop:Rarely necessary
Skin: Stop or Continue? What I do-Consult with Dermatology and then.….
91
NMSC – Basal Cell Squamous Cell
Melanoma PSORIASIAS-like(Immune mediated)
Thiopurine Continue or start:Active or Past, as long as Dermatology monitoring
Stop:Only if significant recurrence or potential for disfiguring sequelae
Continue/start:-eradicated-melanoma free for > 1 yr-no mets
Stop: New Onset?
antiTNF Continue or start:Active or Past, as long as Dermatology monitoring
Stop:Rarely necessary
Continue/start:-eradicated-melanoma free for > 1 yr-no mets
Stop: New Onset
Skin: Stop or Continue? What I do-Consult with Dermatology and then.….
92
NMSC – Basal Cell Squamous Cell
Melanoma PSORIASIAS-like(Immune mediated)
Thiopurine Continue or start:Active or Past, as long as Dermatology monitoring
Stop:Only if significant recurrence or potential for disfiguring sequelae
Continue/start:-eradicated-melanoma free for > 1 yr-no mets
Stop: New Onset?
Continue or start:
-any psoriasis, past or present
- MTX may be useful in rxing antiTNF-mediated skin ds
antiTNF Continue or start:Active or Past, as long as Dermatology monitoring
Stop:Rarely necessary
Continue/start:-eradicated-melanoma free for > 1 yr-no mets
Stop: New Onset
Skin: Stop or Continue? What I do-Consult with Dermatology and then.….
93
NMSC – Basal Cell Squamous Cell
Melanoma PSORIASIAS-like(Immune mediated)
Thiopurine Continue or start:Active or Past, as long as Dermatology monitoring
Stop:Only if significant recurrence or potential for disfiguring sequelae
Continue/start:-eradicated-melanoma free for > 1 yr-no mets
Stop: New Onset?
Continue or start:
-any psoriasis, past or present
- MTX may be useful in rxing antiTNF-mediated skin ds
antiTNF Continue or start:Active or Past, as long as Dermatology monitoring
Stop:Rarely necessary
Continue/start:-eradicated-melanoma free for > 1 yr-no mets
Stop: New Onset
Continue:Mild, <5% skin, responds to topical tx or MTX
Stop:>5%, nonresponsive to psoriasis tx
Summary: Stop or Continue Rx?• IMMs and biologics are associated with rare, but potentially
serious AEs
• Most AEs do not mandate IMM/antiTNF cessation – individualize the decision
• I would stop/hold IMM/antiTNF for:– Active opportunistic infections (rare)– Lymphoma/Cancer (very rare)– Recurrent skin cancers– Non-responsive psoriasis to antiTNF– Allergic/idiosyncratic drug rxns
• Once AE resolves, usually restart meds
94
UPMC IBD Center: Physicians and Staff
When you go out tonight, beware of:When you go out tonight, beware of:
97Bill Sandborn and Jean Fred Colombel